Stay updated on Pirfenidone in COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Pirfenidone in COVID-19 Clinical Trial page.

Latest updates to the Pirfenidone in COVID-19 Clinical Trial page
- Check6 days agoChange DetectedAdded a new site revision indicator (v3.4.1) and removed the prior government-funding notice along with the earlier revision (v3.4.0).SummaryDifference0.5%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded a glossary toggle and updated metadata labels, including a new 'Revision: v3.4.0' and capitalization changes for 'No FEAR Act Data' versus 'No FEAR Act data'. Older QC-related wording such as 'Last Update Submitted that met QC Criteria' was replaced with 'Last Update Submitted that Met QC Criteria' and capitalization standardized; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check27 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4.SummaryDifference0.1%

- Check58 days agoChange DetectedLocations section added with a new site in Hubei, China. Page revision updated to v3.3.3.SummaryDifference0.2%

- Check79 days agoChange DetectedThe revision history now shows Revision: v3.3.2 and removes Revision: v3.3.1.SummaryDifference0.1%

- Check86 days agoChange DetectedMinor wording adjustment in the Publications section (changing 'results of the study' to 'study results') and an update of the revision tag from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pirfenidone in COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pirfenidone in COVID-19 Clinical Trial page.